Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 1
1950 1
1952 3
1955 1
1957 2
1960 2
1962 1
1963 1
1964 9
1965 3
1966 6
1967 10
1968 21
1969 14
1970 21
1971 25
1972 23
1973 18
1974 22
1975 33
1976 38
1977 28
1978 25
1979 26
1980 50
1981 29
1982 30
1983 45
1984 43
1985 46
1986 53
1987 50
1988 46
1989 51
1990 65
1991 64
1992 60
1993 79
1994 82
1995 109
1996 113
1997 125
1998 137
1999 118
2000 152
2001 129
2002 145
2003 128
2004 129
2005 158
2006 155
2007 177
2008 173
2009 186
2010 212
2011 209
2012 241
2013 264
2014 273
2015 256
2016 283
2017 267
2018 308
2019 365
2020 393
2021 375
2022 286
2023 254
2024 113

Text availability

Article attribute

Article type

Publication date

Search Results

6,550 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Neoplasm of striated muscle"
Page 1
Definition and classification of cancer cachexia: an international consensus.
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Fearon K, et al. Lancet Oncol. 2011 May;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7. Epub 2011 Feb 4. Lancet Oncol. 2011. PMID: 21296615 Review.
Cancer cachexia was defined as a multifactorial syndrome defined by an ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment. ...The ag …
Cancer cachexia was defined as a multifactorial syndrome defined by an ongoing loss of skeletal muscle mass (with or without l …
The role of extracellular vesicles in skeletal muscle wasting.
Zhang X, Zhao Y, Yan W. Zhang X, et al. J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2462-2472. doi: 10.1002/jcsm.13364. Epub 2023 Oct 22. J Cachexia Sarcopenia Muscle. 2023. PMID: 37867162 Free PMC article. Review.
Skeletal muscle wasting is a complicated metabolic syndrome accompanied by multiple diseases ranging from cancer to metabolic disorders and infectious conditions. ...This review aims to illustrate the current knowledge about the biological function of EVs cargoes in …
Skeletal muscle wasting is a complicated metabolic syndrome accompanied by multiple diseases ranging from cancer to metabolic …
Sarcopenia and malignancies: epidemiology, clinical classification and implications.
Zhang FM, Wu HF, Shi HP, Yu Z, Zhuang CL. Zhang FM, et al. Ageing Res Rev. 2023 Nov;91:102057. doi: 10.1016/j.arr.2023.102057. Epub 2023 Sep 2. Ageing Res Rev. 2023. PMID: 37666432 Review.
Sarcopenia is a progressive systemic skeletal muscle disorder characterized by a pathological decline in muscle strength, quantity, and quality, which frequently affects the elderly population. ...
Sarcopenia is a progressive systemic skeletal muscle disorder characterized by a pathological decline in muscle strengt …
The role of myokines in cancer: crosstalk between skeletal muscle and tumor.
Park SY, Hwang BO, Song NY. Park SY, et al. BMB Rep. 2023 Jul;56(7):365-373. doi: 10.5483/BMBRep.2023-0064. BMB Rep. 2023. PMID: 37291054 Free PMC article. Review.
Loss of skeletal muscle mass is a primary feature of sarcopenia and cancer cachexia. ...During the past decade, skeletal muscle has been considered to function as an autocrine, paracrine, and endocrine organ by releasing numerous myokines. ...
Loss of skeletal muscle mass is a primary feature of sarcopenia and cancer cachexia. ...During the past decade, skeletal …
Update on molecular findings in rhabdomyosarcoma.
El Demellawy D, McGowan-Jordan J, de Nanassy J, Chernetsova E, Nasr A. El Demellawy D, et al. Pathology. 2017 Apr;49(3):238-246. doi: 10.1016/j.pathol.2016.12.345. Epub 2017 Feb 27. Pathology. 2017. PMID: 28256213 Review.
Rhabdomyosarcoma (RMS) is the most common malignant soft tissue tumour in children and adolescents. Histologically RMS resembles developing fetal striated skeletal muscle. RMS is stratified into different histological subtypes which appear to influence manage …
Rhabdomyosarcoma (RMS) is the most common malignant soft tissue tumour in children and adolescents. Histologically RMS resembles developing …
Skeletal muscle radiodensity and cancer outcomes: A scoping review of the literature.
Scopel Poltronieri T, de Paula NS, Chaves GV. Scopel Poltronieri T, et al. Nutr Clin Pract. 2022 Oct;37(5):1117-1141. doi: 10.1002/ncp.10794. Epub 2021 Nov 9. Nutr Clin Pract. 2022. PMID: 34752653 Review.
The aim of this review was to summarize the methodologies applied for low skeletal muscle radiodensity (SMD) assessment in oncology patients, as well as to describe the major findings related to SMD and cancer outcomes. ...
The aim of this review was to summarize the methodologies applied for low skeletal muscle radiodensity (SMD) assessment in onc …
Muscle dysfunction in cancer patients.
Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, Hojman P. Christensen JF, et al. Ann Oncol. 2014 May;25(5):947-58. doi: 10.1093/annonc/mdt551. Epub 2014 Jan 8. Ann Oncol. 2014. PMID: 24401927 Free article. Review.
BACKGROUND: Muscle dysfunction is a prevalent phenomenon in the oncology setting where patients across a wide range of diagnoses are subject to impaired muscle function regardless of tumor stage and nutritional state. ...Significant progress has been made over the l …
BACKGROUND: Muscle dysfunction is a prevalent phenomenon in the oncology setting where patients across a wide range of diagnoses are …
Imaging of muscle tumors.
Weatherall P. Weatherall P. Semin Musculoskelet Radiol. 2000;4(4):435-58. doi: 10.1055/s-2000-13170. Semin Musculoskelet Radiol. 2000. PMID: 11371328 Review.
Tumors that involve skeletal muscle are numerous and varied, including a variety of benign and malignant neoplasms as well as other mass lesions. ...Although the MRI features of the various muscle masses are variable, general rules regarding characteri …
Tumors that involve skeletal muscle are numerous and varied, including a variety of benign and malignant neoplasms as w …
6,550 results